Last week, Dara Pharma Group took part in the CPHI & PMEC China fair held in Shanghai, where the global pharmaceutical industry met again face-to-face to present the most innovative solutions.
CPHI & PMEC China is the leading pharmaceutical machinery show in Asia, though it strongly focuses on the Chinese market, considered one of the world's largest ones and which has great prospects for growth.
The current edition meant the return of international visitors after Covid, gathering more than 55,000 attendees, 3,300 exhibitors, and 80 conferences focused on the very latest trends in the pharma sector.
Together with the company Jerempli - their local agent - Dara Pharma and Coolvacuum exhibited at the event aseptic filling and freeze-drying equipment, such as the filling and closing machine for vials with RayDyLyo caps, syringes, and cartridges in Nest, model NFL/2-RDL, and the freeze-dryer for laboratory, model LyoMicron.
Both machines left excellent impressions on the attendees who visited the booth, coming not only from China but from the Philippines, Vietnam, Thailand, South Korea, and the European Union as well.
This positive feedback allowed us to generate different business opportunities, especially in equipment for Nest production, that will enable Dara Pharma and Coolvacuum to keep strengthening their presence in the Asian market.
It is particularly worth mentioning the growing interest in the fair for biopharmaceutical products, for which processing Dara Pharma already has solid experience providing equipment and production lines for leading biotech companies.
Overall, Dara Pharma and Coolvacuum are beyond satisfied with their participation in the event, as they got the chance to increase the sales network and consolidate existing projects.
Furthermore, the event confirmed the forecasts that indicate a rise in the demand for aseptic packaging equipment and complete lines in China, a market in which the group has great potential to continue growing.
Discover Dara Pharma's upcoming tradeshows and events at the following link.